Literature DB >> 26327125

Maturation- and sex-sensitive depression of hippocampal excitatory transmission in a rat schizophrenia model.

Eti Patrich1, Yael Piontkewitz2, Asher Peretz3, Ina Weiner4, Bernard Attali5.   

Abstract

Schizophrenia is associated with behavioral and brain structural abnormalities, of which the hippocampus appears to be one of the most consistent region affected. Previous studies performed on the poly I:C model of schizophrenia suggest that alterations in hippocampal synaptic transmission and plasticity take place in the offspring. However, these investigations yielded conflicting results and the neurophysiological alterations responsible for these deficits are still unclear. Here we performed for the first time a longitudinal study examining the impact of prenatal poly I:C treatment and of gender on hippocampal excitatory neurotransmission. In addition, we examined the potential preventive/curative effects of risperidone (RIS) treatment during the peri-adolescence period. Excitatory synaptic transmission was determined by stimulating Schaffer collaterals and monitoring fiber volley amplitude and slope of field-EPSP (fEPSP) in CA1 pyramidal neurons in male and female offspring hippocampal slices from postnatal days (PNDs) 18-20, 34, 70 and 90. Depression of hippocampal excitatory transmission appeared at juvenile age in male offspring of the poly I:C group, while it expressed with a delay in female, manifesting at adulthood. In addition, a reduced hippocampal size was found in both adult male and female offspring of poly I:C treated dams. Treatment with RIS at the peri-adolescence period fully restored in males but partly repaired in females these deficiencies. A maturation- and sex-dependent decrease in hippocampal excitatory transmission occurs in the offspring of poly I:C treated pregnant mothers. Pharmacological intervention with RIS during peri-adolescence can cure in a gender-sensitive fashion early occurring hippocampal synaptic deficits.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antipsychotic drugs; Hippocampus; Maternal immune activation; Poly I:C; Risperidone; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26327125     DOI: 10.1016/j.bbi.2015.08.021

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  10 in total

1.  Neonatal curcumin treatment restores hippocampal neurogenesis and improves autism-related behaviors in a mouse model of autism.

Authors:  Hongyu Zhong; Rui Xiao; Ruotong Ruan; Hui Liu; Xin Li; Yun Cai; Jinghui Zhao; Xiaotang Fan
Journal:  Psychopharmacology (Berl)       Date:  2020-08-15       Impact factor: 4.530

2.  Maternal immune activation alters glutamic acid decarboxylase-67 expression in the brains of adult rat offspring.

Authors:  Sarah N Cassella; Ann M Hemmerle; Kerstin H Lundgren; Tara L Kyser; Rebecca Ahlbrand; Stefanie L Bronson; Neil M Richtand; Kim B Seroogy
Journal:  Schizophr Res       Date:  2016-01-29       Impact factor: 4.939

Review 3.  Brain changes in a maternal immune activation model of neurodevelopmental brain disorders.

Authors:  Lara Bergdolt; Anna Dunaevsky
Journal:  Prog Neurobiol       Date:  2018-12-24       Impact factor: 11.685

4.  Maternal Immune Activation Causes Behavioral Impairments and Altered Cerebellar Cytokine and Synaptic Protein Expression.

Authors:  Gurudutt Pendyala; Shinnyi Chou; Yoosun Jung; Pierluca Coiro; Elizabeth Spartz; Ragunathan Padmashri; Ming Li; Anna Dunaevsky
Journal:  Neuropsychopharmacology       Date:  2017-01-19       Impact factor: 7.853

5.  Maternal Immune Activation during Pregnancy Alters the Behavior Profile of Female Offspring of Sprague Dawley Rats.

Authors:  Brittney R Lins; Wendie N Marks; Nadine K Zabder; Quentin Greba; John G Howland
Journal:  eNeuro       Date:  2019-04-19

Review 6.  Sex and gender bias in the experimental neurosciences: the case of the maternal immune activation model.

Authors:  Pierluca Coiro; Daniela D Pollak
Journal:  Transl Psychiatry       Date:  2019-02-14       Impact factor: 6.222

Review 7.  Sex-Dependent Effects of Perinatal Inflammation on the Brain: Implication for Neuro-Psychiatric Disorders.

Authors:  Maryam Ardalan; Tetyana Chumak; Zinaida Vexler; Carina Mallard
Journal:  Int J Mol Sci       Date:  2019-05-08       Impact factor: 5.923

8.  Modulating microglia activation prevents maternal immune activation induced schizophrenia-relevant behavior phenotypes via arginase 1 in the dentate gyrus.

Authors:  Yucen Xia; Zhiqing Zhang; Weipeng Lin; Jinglan Yan; Chuan'an Zhu; Dongmin Yin; Su He; Yang Su; Nenggui Xu; Robert William Caldwell; Lin Yao; Yongjun Chen
Journal:  Neuropsychopharmacology       Date:  2020-06-29       Impact factor: 7.853

9.  Altered offspring neurodevelopment in an arginine vasopressin preeclampsia model.

Authors:  Serena Banu Gumusoglu; Akanksha Sri Satya Chilukuri; Benjamin Wen Qing Hing; Sabrina Marie Scroggins; Sreelekha Kundu; Jeremy Anton Sandgren; Mark Kharim Santillan; Donna Ann Santillan; Justin Lewis Grobe; Hanna Elizabeth Stevens
Journal:  Transl Psychiatry       Date:  2021-01-28       Impact factor: 6.222

10.  Late prenatal immune activation causes hippocampal deficits in the absence of persistent inflammation across aging.

Authors:  Sandra Giovanoli; Tina Notter; Juliet Richetto; Marie A Labouesse; Stéphanie Vuillermot; Marco A Riva; Urs Meyer
Journal:  J Neuroinflammation       Date:  2015-11-25       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.